Prem S. Shah - Apr 1, 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Co-President of Retail
Signature
/s/ Prem S. Shah
Stock symbol
CVS
Transactions as of
Apr 1, 2022
Transactions value $
$1,931,021
Form type
4
Date filed
4/5/2022, 07:26 PM
Previous filing
Mar 31, 2022
Next filing
Apr 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Tax liability -$1.9M -18.7K -31.74% $101.09 40.3K Apr 1, 2022 Direct F1
transaction CVS Common Stock Tax liability -$377K -3.73K -7.42% $101.09 46.6K Apr 1, 2022 Direct F2
holding CVS Common Stock (pep) 4.41K Apr 1, 2022 Direct F3
holding CVS Common Stock (restricted) 18.4K Apr 1, 2022 Direct
holding CVS ESOP Common Stock 4.54K Apr 1, 2022 Direct
holding CVS Common Stock (restricted) 1.87K Apr 1, 2022 Direct F4
holding CVS Stock Unit (deferred) 5.67K Apr 1, 2022 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $4.2M +41.6K $101.09 41.6K Apr 1, 2022 Common Stock 41.6K $101.09 Direct F6
holding CVS Stock Option 2.94K Apr 1, 2022 Common Stock 2.94K $104.82 Direct F7
holding CVS Stock Option 1.69K Apr 1, 2022 Common Stock 1.69K $62.20 Direct F8
holding CVS Stock Option 12.6K Apr 1, 2022 Common Stock 12.6K $54.19 Direct F9
holding CVS Stock Option 34.3K Apr 1, 2022 Common Stock 34.3K $58.34 Direct F10
holding CVS Stock Option 32.8K Apr 1, 2022 Common Stock 32.8K $74.30 Direct F11
holding CVS Stock Option 26.6K Apr 1, 2022 Common Stock 26.6K $75.24 Direct F12
holding CVS Phantom Stock Credits 11.3K Apr 1, 2022 Common Stock 11.3K $1.00 Direct F13, F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022.
F2 Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.
F3 Consists of Matching RSUs awarded pursuant to Issuer's Partnership Equity Program, a sub-plan under its ICP, and dividend equivalents on the Matching RSUs. Restrictions lapse on the RSUs on 08/31/2023.
F4 Consists of RSUs awarded pursuant to Issuer's Performance-Based Restricted Stock Plan under its 2017 ICP. Restrictions lapse in three equal installments commencing on 02/26/2022.
F5 Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
F6 Option becomes exercisable in four equal installments, commencing 4/1/2023.
F7 Option becomes exercisable in four equal installments commencing 04/01/2017.
F8 Option becomes exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised.
F9 Option becomes exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised.
F10 Option becomes exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised.
F11 Option becomes exercisable in three equal installments commencing 04/01/2022.
F12 Option vests in three equal installments, on 8/31/2021, 8/31/2022 and 8/31/2023.
F13 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F14 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.